Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Pulmonary Embolism 2Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Hemorrhage 1

Interventions

Tranexamic Acid 6Sodium Chloride 2Ringer's Lactate 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Uterine Artery Embolization 1Tourniquets 1Sutures 1Surgicel 1Saline Solution 1Rivaroxaban 1Ringer's Solution 1Pancreaticoduodenectomy 1Mannitol 1Lenalidomide 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1Furosemide 1FloSeal Matrix 1Esomeprazole 1Data Collection 1Dalteparin 1Crystalloid Solutions 1Colloids 1Blood Transfusion 1Bevacizumab 1Aspirin 1Arginine Vasopressin 1Arginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemorrhage × bemiparin × Clear all
NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡